A Study of Single and Multiple Dose Administration of LP-001 in Healthy Subjects

Clinical trial NCT06294275 · COMPLETED

Trial details

NCT number: NCT06294275
Sponsor: Longbio Pharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndrome (MDS)

Start date: 2022-09-03
Primary completion: 2023-08-16
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.